Alliancebernstein Holding

Tempus AI

Vistra

Nancy Pelosi's 2026 Investment Playbook: AI, Defensive Dividends & Leverage

Tempus AI's 15min chart signals MACD Death Cross, KDJ Death Cross.

Twist Bioscience

WeRide

10x Genomics

Cathie Wood's ARK Invest Pivots to AI Stocks, Dumps Genomics Companies

Anglogold Ashanti

Booz Allen Hamilton

AngloGold Ashanti, Tempus AI, and Booz Allen Hamilton See Notable Options Activity

Tempus AI's 15min chart indicates Bollinger Bands Narrowing and Bearish Marubozu pattern.

Catalyst<ul> <li>A MACD Golden Cross on January 6 and a Dark Cloud Cover with bullish bias on January 23 suggest potential upward momentum in TEM's technical indicators.</li></ul>Risk<ul> <li>Bearish technical signals are dominant with three bearish versus one bullish indicators, indicating a challenging near-term bias.</li> <li>Fund flows are predominantly negative across small, medium, and extra-large orders, reflecting cautious or negative investor sentiment.</li></ul>

Key Factors

Tempus AI (TEM) acquired Paige, an AI-driven digital pathology company, to expand its capabilities in precision medicine and capitalize on the growing AI pathology market.Tempus AI's stock surged 6.3% following the acquisition and launch of Paige Predict, an AI-powered digital pathology application.Cathie Wood's ARK Invest purchased $505,380 in Tempus AI shares, reflecting a strategic pivot toward AI-driven technology and away from biotechnology and genomics sectors.Representative Nancy Pelosi's investment roadmap included call options on Tempus AI, highlighting AI as a key focus for her 2026 portfolio strategy.Tempus AI (TEM) experienced notable options activity, with 28,216 contracts traded, representing 2.8 million underlying shares, indicating heightened investor interest in the stock.

Recent Updates

TEM News